HERTFORDSHIRE, England and
PITTSBURGH, March 4, 2016 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today announced that the Company will present
at the Raymond James 37th Annual Institutional Investors Conference
on Wednesday, March 9, 2016, in
Orlando. The presentation is
scheduled to begin at 10:25 a.m.
ET.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's Web site at
www.mylan.com/investors.
About Mylan
Mylan is a global pharmaceutical company
committed to setting new standards in healthcare. Working together
around the world to provide 7 billion people access to high quality
medicine, we innovate to satisfy unmet needs; make reliability and
service excellence a habit; do what's right, not what's easy; and
impact the future through passionate global leadership. We offer a
growing portfolio of more than 1,400 generic and branded
pharmaceuticals, including antiretroviral therapies on which nearly
50% of people being treated for HIV/AIDS in the developing world
depend. We market our products in approximately 165 countries and
territories. Our global R&D and manufacturing platform includes
more than 50 facilities, and we are one of the world's largest
producers of active pharmaceutical ingredients. Every member of our
nearly 35,000-strong workforce is dedicated to creating better
health for a better world, one person at a time. Learn more at
mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-raymond-james-37th-annual-institutional-investors-conference-300231014.html
SOURCE Mylan N.V.